Company Profile · Healthcare

Bio-Rad Laboratories Inc

BIO · US
Exchange
US
Country
USA
IPO date
Jan 1, 1966
Employees
7,450
Current Price
$282.44
Live · Jun 22, 2026
Fair Buy
≤ $190
Margin-of-safety entry
Baillie Growth Score
45/100
Weak
Intrinsic Value · Three-Tier Range Current price $282.44 Live · Within the fair intrinsic-value range

Composite valuation range · conservative $170–$190 / fair $276–$374 / optimistic $466–$510. At $282.44, Within the fair intrinsic-value range.

At publication $297.09 (Jul 2, 2026)

May 18, 2026 Update Needs review

Elliott reportedly builds sizable stake in Bio-Rad

WSJ reported Elliott built a sizable Bio-Rad stake and plans to push for improved share performance.

Possible impact:May affect expectations for governance changes, asset value realization and possible strategic actions.

The Wall Street JournalView source

Automatically summarized from public sources; for context only, not investment advice.

Market cap$8.05B
Revenue (TTM)$2.59B
EBITDA$444.8M
Profit margin6.52%
ROE2.5%
P/E (TTM)49.97
Forward P/E34.01
PEG1.19
EPS$6.02
52-week range$236.73 – $343.12
Analyst target$297.00
Analyst rating4.0 / 5

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

Bio-Rad Laboratories, Inc. develops, manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, Latin America, and internationally. It operates through two segments, Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantify biological materials, including cells, proteins, and nucleic acids used in research and biopharmaceutical laboratory environments, as well as for biopharmaceutical manufacturing, quality control process, food safety, and science education applications. This segment serves universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology companies, food producers, and testing laboratories. Its Clinical Diagnostics segment designs, manufactures, markets, and supports diagnostic test systems, informatics systems, test kits, and specialized quality controls for clinical, hospital, diagnostic reference, and transfusion and physician office laboratories, as well as software. The company offers its products through its direct commercial organization, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.